These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19527805)

  • 41. [THE PRESENT PLACE OF PERITONEAL DIALYSIS AMONG METHODS OF EXTRARENAL PURIFICATION. (APROPOS OF 100 PATIENTS WITH ACUTE AND CHRONIC RENAL INSUFFICIENCY)].
    DELAVAL E
    Anesth Analg (Paris); 1964; 21():405-12. PubMed ID: 14180372
    [No Abstract]   [Full Text] [Related]  

  • 42. Overview of regular dialysis treatment in Japan (as of 31 December 2008).
    Nakai S; Suzuki K; Masakane I; Wada A; Itami N; Ogata S; Kimata N; Shigematsu T; Shinoda T; Syouji T; Taniguchi M; Tsuchida K; Nakamoto H; Nishi S; Nishi H; Hashimoto S; Hasegawa T; Hanafusa N; Hamano T; Fujii N; Marubayashi S; Morita O; Yamagata K; Wakai K; Watanabe Y; Iseki K; Tsubakihara Y
    Ther Apher Dial; 2010 Dec; 14(6):505-40. PubMed ID: 21118359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'.
    Cuoghi A; Caiazzo M; Monari E; Bellei E; Bergamini S; Sereni L; Aucella F; Loschiavo C; Atti M; Tomasi A
    J Biomater Appl; 2015 May; 29(10):1363-71. PubMed ID: 25542733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dialysis for end-stage renal disease.
    Walker JA; Dodelson R; Eisinger RP
    J Med Soc N J; 1984 Dec; 81(12):1067-74. PubMed ID: 6595420
    [No Abstract]   [Full Text] [Related]  

  • 45. Can dialysis remove protein bound toxins that accumulate because of renal secretory failure?
    Gulyassy PF
    ASAIO J; 1994; 40(1):92-4. PubMed ID: 8186502
    [No Abstract]   [Full Text] [Related]  

  • 46. Establishment of a blood purification system for renal failure rats using small-size dialyzer membranes.
    Yorimitsu D; Satoh M; Koremoto M; Haruna Y; Nagasu H; Kuwabara A; Sasaki T; Kashihara N
    Ther Apher Dial; 2012 Dec; 16(6):566-72. PubMed ID: 23190517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oxidative stress in patients on regular hemodialysis and peritoneal dialysis].
    Vostálová J; Galandáková A; Strebl P; Zadražil J
    Vnitr Lek; 2012 Jun; 58(6):466-72. PubMed ID: 22913239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():89-95. PubMed ID: 6619036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracorporal blood purification: more than diffusion and convection. Does this help?
    Ronco C; Tetta C
    Curr Opin Crit Care; 2007 Dec; 13(6):662-7. PubMed ID: 17975387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration.
    Krieter DH; Falkenhain S; Chalabi L; Collins G; Lemke HD; Canaud B
    Kidney Int; 2005 Jan; 67(1):349-56. PubMed ID: 15610261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Albumin-bound substances--a new target in liver failure therapy.
    Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
    [No Abstract]   [Full Text] [Related]  

  • 53. Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
    Ash SR
    Ther Apher; 2001 Oct; 5(5):404-16. PubMed ID: 11778927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does convective dialysis therapy applied daily approach renal blood purification?
    Ledebo I
    Kidney Int Suppl; 2001 Feb; 78():S286-91. PubMed ID: 11169028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-sites polycyclodextrin adsorbents for removal of protein-bound uremic toxins combining with hemodialysis.
    Li J; Han L; Xie J; Liu S; Jia L
    Carbohydr Polym; 2020 Nov; 247():116665. PubMed ID: 32829793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of peritoneal-extracorporeal shunting for refractory hemodialysis ascites.
    Hida M; Takamiya T; Iida T; Kitajima N; Hiraga S; Satoh T
    Tokai J Exp Clin Med; 1987 May; 12(2):79-81. PubMed ID: 3449987
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood purification in acute renal failure.
    Twardowski ZJ; Nolph KD
    Ann Intern Med; 1984 Mar; 100(3):447-9. PubMed ID: 6696361
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
    Huster D; Schubert C; Achenbach H; Caca K; Mössner J; Berr F
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():13-4. PubMed ID: 16215886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma.
    Tijink MS; Wester M; Glorieux G; Gerritsen KG; Sun J; Swart PC; Borneman Z; Wessling M; Vanholder R; Joles JA; Stamatialis D
    Biomaterials; 2013 Oct; 34(32):7819-28. PubMed ID: 23876759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.